Join us for an update with Saundra Pelletier and Amy Raskopf who will be presenting on Thursday Aug 1st, 10:30am ET, at the OTCQB Virtual Investor Conference. Join us: https://bit.ly/3LySuJN $EVFM #WomensHealth
Evofem Biosciences
Biotechnology Research
San Diego, CA 9,291 followers
Developing and commercializing products that address unmet needs in women’s sexual and reproductive health.
About us
Evofem Biosciences, Inc., (OTCQB: EVFM) is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health In September 2020, Evofem launched Phexxi, the first and only hormone-free, on-demand, prescription birth control available in the U.S. that women use only when they have sex.
- Website
-
http://www.evofem.com
External link for Evofem Biosciences
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- San Diego, CA
- Type
- Public Company
- Founded
- 2015
Locations
-
Primary
Get directions
12636 High Bluff Dr.
Suite 400
San Diego, CA 92130, US
Employees at Evofem Biosciences
Updates
-
We are very excited to announce our first ex-U.S. license agreement with Pharma 1, to commercialize Phexxi in the Middle East! Please read all about it: https://lnkd.in/gUBdek4J
Evofem Signs Phexxi® License Agreement for Middle East with Pharma 1
evofem.investorroom.com
-
We are pleased to share we have acquired Lupin's women's health business - now adding SOLOSEC® (secnidazole) 2g oral granules, an FDA-approved, single-dose oral treatment for two common sexual health infections, to our commercial portfolio of innovative sexual health drugs. This acquisition aligns with our strategy to leverage our U.S. women's health-focused sales organization, and marks an important milestone for the company and a new chapter in our evolution. https://lnkd.in/gxzb-DW6
Lupin Divests U.S. Commercial Women's Health Specialty Business - SOLOSEC - to Evofem Biosciences
evofem.investorroom.com
-
We are pleased to announce our partnership with Hello Alpha to offer Phexxi® as a hormone-free contraception solution on its platform for women’s healthcare! https://lnkd.in/g7sYef2k
-
Evofem Biosciences reposted this
Chief Executive Officer, President, and Executive Director of Evofem Biosciences (OTCQB: EVFM)
Thank you, Newsweek, for shedding light on the critical public health issue of stealthing and highlighting the importance of innovative contraceptive solutions. This conversation is essential for advancing reproductive rights and empowering women to take control of their own health. Together, we can create a safer, more informed world. #ReproductiveHealth #EndStealthing #Contraception #PublicHealth
Birth control gel aims to protect against condom 'stealthing'
newsweek.com
-
🌈✨ Happy Pride Month from Evofem! 🏳️🌈 Let's celebrate love, diversity, and equality together. We're proud to stand with the LGBTQ+ community today and every day. Here's to a world where everyone can live and love freely! #PrideMonth #LoveIsLove #Inclusion 🌈💖
-
-
We are pleased to announce our fifth U.S. patent for Phexxi that will be listed in FDA's Orange Book. This further strengthens our IP and attests to the innovation Phexxi brings to contraception. https://lnkd.in/gcXFETts
Evofem Announces Issuance of New U.S. Patent Covering Phexxi Composition of Matter
evofem.investorroom.com
-
Evofem Biosciences Announces Financial Results for the First Quarter of 2024 To view this release online and get more information about Evofem: IR Room visit: https://lnkd.in/eNXznMGU
Evofem Biosciences Announces Financial Results for the First Quarter of 2024
evofem.investorroom.com
-
Thank you YourChoice Therapeutics for recognizing Saundra Pelletier and Phexxi!
It's #womenshealthweek! On this 1st day, we're naming Saundra Pelletier a #womenshealthhero. Saundra is the CEO of Evofem Biosciences, which has created a hormone-free contraceptive for women that's used only when needed! We believe this tremendous innovation in birth control--arguably the first real one in 60+ years--will have a direct and profound impact on women's health. This month, we're celebrating the people and organizations that are working hard to improve #birthcontrol, birth control #access and support more #malebirthcontrol options. We think Saundra is a fierce women's health warrior. Check out her Tedx and get ready to be inspired. Like and comment our #womenshealthwarriors. We'll share your favorite at the end of the month. https://lnkd.in/e4fHKVQH
-
-
We are pleased to share we have strengthen our Phexxi IP with a new composition of matter patent - this will be Evofem’s fifth Orange Book-listed patent for Phexxi in the United States. #contraception #hormonefreecontraception https://lnkd.in/g49HFmYd
Evofem Strengthens Phexxi Intellectual Property with New Composition of Matter Patent From USPTO
evofem.investorroom.com